Back to search

University of Kent,

Nanocarriers for the Targeted Delivery of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to Tumours

Abstract

dc:description.abstract

A growing body of evidence suggests that the regular use of non-steroidal anti-inflammatory drugs (NSAIDs), especially aspirin, is associated with a reduced risk of many types of cancer including colorectal, breast, and prostate malignancies. It has also been shown that they might be beneficial in reducing metastasis and lengthening remission periods. However, the prolonged exposure to this class of drugs does not come without a cost as it carries with it the risk of augmenting the serious side effects of NSAIDs. These include haemorrhages, increased bleeding time, peptic ulcers, and hypersensitivity, to name a few. This work aimed at employing the principles of nanotherapy to maximise the benefits of NSAIDs and minimise the risks of their harmful side effects. By exploiting the enhanced permeability and retention effect (EPR) unique to inflammatory tissues, NSAID-loaded nanocarriers could deliver high concentrations of the drugs to cancer tissue, compared to conventional therapy, while reducing the systemic exposure to their effects.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Kent,
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Akkad, Mhd Saeed
Advisor dc:contributor.advisor
  • Serpell, Christopher J.

Subjects

dc:subject × 1

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Kent
Base URL
kar.kent.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Akkad, Mhd Saeed. Nanocarriers for the Targeted Delivery of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to Tumours. doctoral thesis, University of Kent,, 2020.